Skip to Content
Merck
  • Chromosomal aberration arises during somatic reprogramming to pluripotent stem cells.

Chromosomal aberration arises during somatic reprogramming to pluripotent stem cells.

Cell division (2020-12-10)
Xinyu Liu, Conghui Li, Kang Zheng, Xiaofeng Zhao, Xiaofeng Xu, Aifen Yang, Min Yi, Huaping Tao, Binghua Xie, Mengsheng Qiu, Junlin Yang
ABSTRACT

Reprogramming somatic cells to induced pluripotent stem cells (iPSCs) has opened new therapeutic possibilities. However, karyotypic abnormalities detected in iPSCs compromised their utility, especially chromosomal aberrations found at early passages raised serious safety concerns. The mechanism underlying the chromosomal abnormality in early-passage iPSCs is not known. Human dermal fibroblasts (HDFs) were stimulated with KMOS (KLF4, cMYC, OCT4 and SOX2) proteins to enhance their proliferative capacity and many vigorous clones were obtained. Clonal reprogramming was carried out by KMOS mRNAs transfection to confirm the 'chromosomal mutagenicity' of reprogramming process. Subculturing was performed to examine karyotypic stability of iPSCs after the re-establishment of stemness. And antioxidant N-acetyl-cysteine (NAC) was added to the culture medium for further confirmming the mutagenicity in the first few days of reprogramming. Chromosomal aberrations were found in a small percentage of newly induced iPS clones by reprogramming transcription factors. Clonal reprogramming ruled out the aberrant chromosomes inherited from rare karyotypically abnormal parental cell subpopulation. More importantly, the antioxidant NAC effectively reduced the occurrence of chromosomal aberrations at the early stage of reprogramming. Once iPS cell lines were established, they restored karyotypic stability in subsequent subculturing. Our results provided the first line of evidence for the 'chromosomal mutagenicity' of reprogramming process.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-TRA-1-60 Antibody, clone TRA-1-60, Cy3 conjugate, clone TRA-1-60, from mouse, CY3 conjugate
Sigma-Aldrich
Anti-Stage-Specific Embryonic Antigen-4 Antibody, clone MC-813-70, clone MC-813-70, Chemicon®, from mouse
Sigma-Aldrich
Anti-TRA-1-81 Antibody, clone TRA-1-81, Cy3 conjugate, clone TRA-1-81, from mouse, CY3 conjugate
Sigma-Aldrich
Anti-SSEA-1 Antibody, clone MC-480, PE conjugate, clone MC-480, from mouse, PE